0001415889-24-018159.txt : 20240625 0001415889-24-018159.hdr.sgml : 20240625 20240625171554 ACCESSION NUMBER: 0001415889-24-018159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240624 FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vig Pamela CENTRAL INDEX KEY: 0001780069 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 241069919 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 989 EAST HILLSDALE BOULEVARD, SUITE 300 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-06252024_090650.xml X0508 4 2024-06-24 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001780069 Vig Pamela C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300 FOSTER CITY CA 94404 false true false false CHIEF SCIENTIFIC OFFICER 1 Common Stock 2024-06-24 4 M 0 30559 2.936 A 57965 D Common Stock 2024-06-24 4 S 0 30559 34 D 27406 D Common Stock 75000 I By The Vig-Ancock Family Trust Stock Option (right to buy) 2.936 2024-06-24 4 M 0 30559 0 D 2029-03-11 Common Stock 30559 125691 D Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted in March 2024. The stock option is fully vested. /s/ Judit Ryvkin, Attorney-in-Fact 2024-06-25